Amethyst NSCLC Trial: Phase 2 Study of MGCD265 in Patients with Advanced or Metastatic NSCLC with Activating Genetic Alterations in MET

JOURNAL OF THORACIC ONCOLOGY(2017)

引用 0|浏览12
暂无评分
关键词
MET,NSCLC,ctDNA,EXON 14 DELETION
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要